International Stem Cell extends $2.9M CEO loan maturity to Sept 15, 2022

International Stem Cell CORP

Extended maturity of $2.9M promissory note from CEO Andrey Semechkin to Sept 15, 2022 (was Mar 15, 2022).
Note is unsecured, non-convertible, bears 4.5% annual interest.
Loan originated Jan 13, 2022; this new note replaces the original on same principal.
CEO Semechkin is Co-Chairman and CEO; transaction is a related-party financing.
Company may prepay the note at any time without penalty.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.